| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5501847 | Free Radical Biology and Medicine | 2016 | 43 Pages |
Abstract
Allo treatment attenuates renal dysfunction in a model of rhabdomyolysis-associated AKI by reducing oxidative stress (systemic, renal and muscular), apoptosis and inflammation. This may represent a new therapeutic approach for rhabdomyolysis-associated AKI - a new use for an old and widely available medication.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Ageing
Authors
Pedro H.F. Gois, Daniele Canale, Rildo A. Volpini, Daniela Ferreira, Mariana M. Veras, Vinicius Andrade-Oliveira, Niels O.S. Câmara, Maria H.M. Shimizu, Antonio C. Seguro,